Aptima M genitalium: cost and payments to doctors
What Medicare Part D paid pharmacies for Aptima M genitalium, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Gen-probe, Inc.?
Gen-probe, Inc. reported the most payments naming Aptima M genitalium. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $28K
- Providers
- 395
- Transactions
- 472
- Average per transaction
- $59
The per-transaction average — $59 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 395 providers the average total is $70, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Gen-probe, Inc. | $17,604 | 63.7% |
| Hologic, LLC | $6,850 | 24.8% |
| Gen-probe Sales & Service, Inc. | $3,138 | 11.4% |
| Hologic Inc | $32 | 0.1% |
Other products from Gen-probe, Inc.
The company that reported the most payments naming Aptima M genitalium also reports against these.
- Aptima$1,860,075
- THINPREP 2000 PROCESSOR$100,118
- FETAL FIBRONECTIN ENZYME IMMUNOASSAY$66,227
- NONE$62,529
- Aptima HPV$18,148
- co testing$17,249
- Vaginitis$17,249
- PANTHER FUSION$8,000
- Localizer$6,124
- GENIUS AI DETECTION$5,515